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Abstract 
Objectives: to describe how clinicians deal with the uncertainty inherent in medical 
evidence in clinical consultations 
Design: recording and qualitative comparative analysis of clinical consultations 
related to hormone replacement therapy, bone densitometry and breast screening 
Setting: UK National Health Service 6 general practices and 3 secondary care clinics 
Participants: All women aged 45-64 attending the clinic/surgery session invited to 
participate. 109 relevant consultations were recorded. 
Results: 45 consultations included sufficient discussion for analysis of how 
uncertainty inherent in medical evidence was dealt with. The consultations could be 
categorised into three groups to aid understanding and reflection: 
- Focus on certainty ‘for now’ and ‘this test’ with slippage into general reassurance 
- Weaving a coherent account of the medical evidence for risks and benefits but with 
blurring of the uncertainty inherent in the evidence  and giving an impression of 
certainty  
- Acknowledging the inherent uncertainty of the medical evidence and negotiating a 
provisional decision 
Conclusions: There is a dilemma in applying medical evidence to individual patients. 
There are dangers of creating a myth of certainty around what is inherently uncertain. 
Negotiating provisional decisions may avoid this danger. The dilemma needs to be 
remembered when developing and teaching skills for communicating about medical 
evidence in consultations. 
 
Introduction 
 
Clinicians have access to a growing body of good clinical research evidence 
informing them about the effectiveness of many medical interventions. However 
robust the research there is a dilemma for the clinician when applying this research 
evidence to individual patients 1. This is the uncertainty inherent in the nature of 
medical evidence. For example, epidemiology tells us that smoking is a risk factor for 
heart attack but does not tell us which individuals will be affected2. Randomised 
controlled trials of hormone replacement therapy (HRT) 3 tell us the number of extra 
breast cancers identified in a large number of women on HRT compared to those not 
on HRT but this cannot tell us which individual women will develop the extra 
cancers. This dilemma between the nature of medical evidence and individual patient 
care is central to medicine’s history and will not disappear as they are essential to 
each other. Diseases always manifest themselves in the bodies and minds of 
individual patients and in seeking to understand, treat and predict the outcome of 
disease, clinicans need to move their focus from the individual to more generalised 
research4. 
 
Clinicians recognise this dilemma and have reflected on this in relation to their 
clinical practice 2 and the need for research methods that give more attention to the 
‘particular’ rather than the general 5. Its importance is discussed within related 
disciplines including medical philosophy6, ethics7, and health policy8 9. However, few 
studies10 have examined what clinicans actually say to patients. Studies have 
considered how clinicians communicate clinical evidence to the patient, taking 
account of their preferences 11 and maintaining the clinician-patient relationship12. 
Studies acknowledge the difficulty of communicating about risk and benefit of 
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interventions13. However, these studies do not examine the communication in relation 
to the inherent uncertainty in the evidence. This paper examines how clinicians talk to 
patients about this uncertainty, and provides a framework for reflecting on how they 
handle this dilemma of applying clinical evidence to the particular patient. 
 
Method 
 
This paper examines health care consultations with clinicians in both primary and 
secondary care, doctors, nurses and radiographers, dealing with diagnosis, prevention 
and symptom relief. The patients were all women at midlife and the consultations 
were those where there was discussion of one or more of the following interventions: 
hormone replacement therapy (HRT), bone densitometry and breast screening. 
 
Consultations of women aged 45-64 years were recorded in the UK National Health 
Service in 6 general practices and 3 specialist clinics. The study included contrasting 
socio-economic contexts in the Midlands and North East England. This data 
collection was part of a larger study which included interviews with health 
professionals and with women, and is reported elsewhere14 15 . 
 
All women aged 45-64 attending the clinic/surgery session, were invited to 
participate. All recorded consultations were reviewed for their relevance to the study. 
Those with no mention of any of the interventions at the focus of the study, were 
discarded. All other consultations, even with only a passing mention of one of the 
interventions were retained for transcription and analysis. The clinics/surgeries and 
relevant consultations recorded are detailed in table 1 and the research process 
including analysis is detailed in box 1. 
 
There were 109 relevant consultations, 72 from general practice and 37 from 
specialist clinics. In specialist clinics most women agreed to recording; in general 
practice the consent rate was lower, in some surgeries as low as 20%. This may have 
been because women assumed the consultation would not be relevant to the study. 
 
During analysis, a key theme that emerged was uncertainty and how it is discussed 
between health professionals and women, particularly the uncertainty inherent in 
medical evidence when it is applied to particular individuals. This paper reports the 
subsequent analysis of the consultations in relation to this theme. 
 
The data included 64 consultations with only a brief mention of the interventions. For 
example:  
- A woman with symptoms she thinks are due to the menopause, discusses with 
Practice Nurse: HRT mentioned only briefly  
- A woman on Tamoxifen suffers vaginal dryness: HRT mentioned by GP as 
something the woman cannot have 
- In an appointment for a cervical smear, taking the smear was not possible due to 
vaginal soreness. This was the main topic of discussion with the Practice Nurse: 
HRT mentioned as something tried in the past with no benefit 
- Brief discussion of how the mammography service is organised -in a GP 
consultation about other issues 
- Before a bone scan the Radiographer briefly explains to the woman why she is 
having the scan 
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- In a consultation about diabetes, GP checks if woman is happy with her HRT 
while issuing a repeat prescription 
These consultations were not included in subsequent analysis as they contained 
insufficient data to indicate how uncertainty was dealt with. Through a process of 
discussion and constant comparison of the data, a categorisation was developed of 
how the uncertainty was dealt with in the remaining 45 consultations. These 45 
consultations had been recorded from 25 different health professionals. Nine health 
professionals had more than one consultation in this data set and of these three had 
more than two. The consultation categories were developed as a tool for 
understanding and reflecting on what is taking place in the consultations. The results 
of the analysis were presented to three University based focus groups, two of doctors 
and one of patients, which provided feedback on the validity of the categories form 
their own experience. Further comparative analysis explored links between how 
uncertainty was dealt with and the health care issues and context. 
 
Results 
 
Uncertainty and medical evidence 
 
The focus of the analysis was on how uncertainty due to the nature of medical 
evidence was managed within the consultations. The extract in Box 2 provides an 
example of this; the doctor knows what should make a difference to bone density 
based on medical research but he does not know what has made a difference for this 
particular woman. 
 
Three categories were developed of the approach taken within the consultations to the 
uncertainty inherent in medical evidence. 
 
Certainty for now 
The health professionals talked about certainty for now, or for this test, for example a 
an ultrasound result at the time of the ultrasound. However they also slipped into 
general reassurance. 
 
Coherent story of certainty 
The health professionals wove a coherent account of the medical evidence for risks 
and benefits, for example taking HRT for osteoporosis, that included a great deal of 
detail including estimates of the size of risk. However, the way in which the health 
professional delivered this detail gave an impression of certainty, even though the 
health professional may have used words implying uncertainty. 
 
Acknowledging uncertainty 
In these consultations the uncertainty of outcome from using an intervention was 
acknowledged. This included acknowledgement of the inherent uncertainty of the 
medical evidence when it is applied to the individual. Negotiating a provisional 
decision was a strategy used to cope with this uncertainty. 
 
Most consultations included elements of each of the three categories. However it was 
possible to identify a dominant approach to the inherent uncertainty of medical 
evidence in all but four consultations. The latter involved strict use of a protocol or 
were administrative. Of the nine health professionals for whom there was more than 
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one consultation, all except one (a specialist registrar) used more than one approach to 
epistemological uncertainty. The approaches to uncertainty are described below. 
 
Certainty for now 
 
Health professionals talked of certainty in relation to the results of the test they had 
performed or were planning. Reassurance was given before test results were available, 
but with the proviso that the test results were needed to be absolutely sure. For 
example, in two consultations women told the GPs about changes they had noted in 
their breasts. The GPs examine and reassure the women that their breasts seem 
‘normal’ and refer the women to the breast clinic for further certainty from the tests 
they would have (see Box 3 extract 1). A doctor in the breast assessment clinic 
emphasised the need for certainty by saying ‘obviously we need to know for sure’ and 
arranged a biopsy to try and achieve that. He follows this up saying ‘often we biopsy 
things to prove that they’re nothing … we get so many surprises, we’re sort of duty 
bound to offer you the .. chance of biopsy’ (Consultation032). The type of certainty 
being talked about is a test result for the here and now – a particular piece of tissue at 
this time. The mention of ‘surprises’ indicates uncertainty but only until the certain 
results of the biopsy. 
 
In Box 3, extract 2 the doctor talks about certainty provided by the ultrasound result 
for the breast tissue at this time and then goes on to explain to the woman the limited 
nature of this certainty. However, other consultations in this category did not include 
such explanation. The health professionals took care to tell the women that the 
particular tissue examined was ‘normal’ but followed it up with a reassuring phrase 
which was rather general, for example ‘it’s perfectly normal, you’re alright’ 
(Consultation031). 
 
 
Coherent story of certainty 
 
In these consultations the health professional wove together an account or explanation 
for the woman that was coherent, almost as a story. The intention of the health 
professionals seemed to be to provide information and explanation so the woman 
could make her own decisions, although the overall tenor of the consultations was in 
favour of the intervention. In some of the consultations the health professional 
provided a great deal of detailed information including numerical estimates of risk 
and explanation of uncertainty. However, from the way women responded, it seemed 
that for them this formed an unfocused backdrop for their decisions. 
 
In Box 4, extract 1, both the doctor and the woman seem to struggle with 
epistemological uncertainty. The doctor actually contradicts himself in the process of 
trying to provide a coherent account of the risk of osteoporosis. The woman also 
struggles to understand how the evidence applies to her. At one point the doctor links 
his explanation to the woman’s mother’s experience, a reality they both know about. 
However, most of what the doctor says is drawn from evidence based on populations 
(much of this detail has been removed from the extract for brevity). The impression 
this creates is one of certainty about how the evidence applies to this particular 
woman despite the doctor using words and phrases that includes uncertainty and 
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probability. The doctor creates a myth about the certainty of the evidence for this 
woman. 
 
Consultations in general practice tended to be shorter than in specialist clinics, with 
less detail given of the risk and benefits. Some GPs expressed certainty about the 
effect of HRT. For example, in discussing HRT a patient says ‘I don’t really want to 
come off it, if it’s not doing any harm.’ To which the GP replies ‘Not, not any harm at 
all…..’ (Consultation008). In Box 4 extract 2 a different GP gives quite a lot of 
information about the risks and benefits of HRT and the different factors to be 
weighed up for different individuals. However, the tenor of the consultation is of 
weaving a coherent account that indicates that it is possible for each individual to 
work out what is best for them with some certainty. 
 
Acknowledging uncertainty 
 
In Box 5 extract 1, the woman is concerned about the new evidence about HRT. The 
woman has concluded for herself that the risks are small. The doctor backs up the 
woman’s assessment of the risk being small and also explains the difficulty of 
applying population evidence to an individual ‘it’s very difficult to know whether if 
something happens to you whether it’s this or more likely whether it would have 
happened anyway’ (Consultation072). It then becomes clear that for the woman 
having energy for her ‘young lad’ is important to her and given priority over the 
medical risk. A provisional plan is made where by HRT will be used for now but then 
reviewed. It is through this provisional approach that the woman and doctor have 
achieved some integration of future risk from the intervention including the 
uncertainty inherent in the medical evidence, with how things are for the woman in 
the current time and place. 
 
In another consultation (Box 5 extract 2) there is agreement of a provisional plan for a 
reduction in the dosage of HRT, a suggestion that came from the woman. This plan 
integrates the concern about future risk from the HRT with the woman’s experience 
of symptoms, so linking across the gap between the medical evidence and the 
woman’s individual experience. 
 
In a consultation with a practice nurse (Box 5 extract 3) the risks of HRT are 
discussed and the woman describes feeling well. The nurse explaines the risk of breast 
cancer in a manner similar to that described above, weaving a coherent story of the 
risks and benefits. The woman introduces the provisional decision making ‘by then I 
might be okay we'll just have to wait and see’. They agree on continuing the HRT for 
now, aware of the potential risk and of the good quality of life for the woman. 
 
In another consultation (Consultation005) the doctor tells the woman (who has been 
on HRT 6 years for symptom relief, has a family history of breast cancer and has 
annual mammography) that her risk of breast cancer is going up: it is about ‘weighing 
the two up’, ‘it becomes personal choice’. The woman says ‘Will anybody sort of say 
“hey” at a certain point? Or will that be up to me?’. The doctor says ‘I think what 
you’ll find is that there’ll be conversations like this once in a while’, indicating that 
the decision is a provisional one. 
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Usage of the different approaches to uncertainty inherent in the nature of 
medical evidence 
Analysis of the consultations by role of the health professional and type of health care 
setting (table 2) indicates a link between the approach to epistemological uncertainty 
used and the health care site. ‘Certainty for now’ was found in the breast assessement 
clinic. Weaving a ‘coherent story of certainty’ predominated in the HRT/bone clinic 
setting. General practice used all three approaches. The pattern of approach used 
became clearer when explored in relation to the health concern discussed in the 
consultations (see table 3). In all consultations where there was concern about a breast 
problem health professionals used the approach of ‘certainty for now’ with slippage 
into general reassurance. Where the result of bone densitometry and subsequent 
management was discussed, which in some consultations included use of HRT, nearly 
all the consultations used ‘a coherent story of certainty’. In the one consultation on 
this health issue that did not use this approach, further test results were awaited. ‘A 
coherent story of certainty’ was also used for consultations where HRT was initiated 
for other reasons.  The above health issues were discussed in specialist clinics and in 
general practice and by both doctors and nurses. 
 
When reviewing HRT usage or restarting it after a break, ‘acknowledging uncertainty’ 
predominated. However, some health professionals wove a ‘coherent story of 
certainty’ (see table 3). All the consultations on this health issue were recorded in 
general practice. There was no apparent pattern linking the category of the 
consultation and whether the review was initiated by the patient or the health 
professional. 
 
Discussion 
 
For good communication between health professional and patient, health 
professionals need strategies for coping with the dilemma of applying medical 
evidence to individual patients, as it cannot be avoided. These strategies could include 
using provisional decisions that allow for changing priorities and circumstances over 
time, avoiding slippage into general reassurance from a particular test result and 
avoiding the creation of a myth of certainty. 
 
This paper illustrates how health professionals and women have been dealing with the 
dilemma of uncertainty inherent to medical evidence in relation to medical 
interventions focused on midlife women. These interventions offer prevention, 
screening and symptom relief so the results may inform other areas of medicine where 
the type of evidence base is similar, such as prevention and treatment of chronic 
disease. Further research may be needed to examine consultations about acute illness. 
The recorded consultations include examples where the doctor was attempting to 
communicate risk in ways that are known to be unhelpful to patients16, particularly 
when weaving a ‘coherent story of certainty’. Training in clinical communication, 
including how to communicate risk is important. There are many successful models 
for such training. This research is not suggesting a new model but highlights the 
importance of including, in existing training models, an awareness of the dilemma 
involved in applying medical evidence to individual patients and strategies to cope 
with this.  
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In the data the health professionals expressed an understanding of the evidence about 
the risks and benefits of the interventions more or less in line with the prevailing 
medical consensus at the time. However, during data collection new evidence on the 
risks of HRT was published 3 so the content of some of the consultations would now 
be different with less positive accounts of HRT 17 . However, it is the way the 
accounts of the medical evidence are woven together that produces the impression of 
certainty rather than the detail. 
 
The data reveal a danger of creating a myth of certainty around what is inherently 
uncertain through the way the medical evidence is presented and discussed. This 
seems to be particularly so when there is a test result, such as bone densitometry, or 
where an intervention such as HRT is being initiated. This way of presenting evidence 
about a medical intervention reinforces the idea of medicine as a precise science 
independent of context and persons with the ability to predict outcome, which has 
become incorporated into lay models of illness 18. Apparent certainty can be 
persuasive and can lead to the health professional changing their understanding of the 
evidence to fit the story they are presenting to the patient. Part of learning to 
communicate well about risks and benefits of health interventions, and so truly 
include patients in decision making, may be to fully recognise the uncertainties 
inherent in our clinical evidence and not to hide this from patients. Health 
professionals would then stop reinforcing the myth of medicine as a science of 
certainty and prediction and could work creatively with its uncertainties alongside 
patients. 
 
In consultations where HRT was being reviewed or restarted, a provisional decision 
was often agreed. This avoided the danger of further reinforcing the myth of certainty. 
The women interpreted the medical evidence for their current situation 19 including 
their physical symptoms, their hopes and fears, their social situation and priorities14. 
They may have been more able to do this at a review appointment as by then they had 
some personal experience of taking HRT. They may also have sought information 
themselves about the medical evidence, and through this process developed their 
ability to assess the evidence20. 
 
Time is an important dimension in this analysis. The clinicians in the breast clinic 
struggled to stay with the here and now in their desire to reassure the woman. 
Consultations at Bone/HRT specialist clinics included mention of review of treatment 
in three, four or five years. Mention of this length of time added to the impression of 
certainty rather than implying something provisional. In contrast to the other 
categories the use of time by making provisional plans was the striking feature of the 
third category ‘acknowledging the uncertainty’. This fits with the lived reality for 
women, as their context and experience changes over time, as does their level of risk. 
The consultations in our third category ‘acknowledging the uncertainty’ may provide 
useful examples of using time in decisions related to health 1 for use in the teaching of 
communication skills as they demonstrate how a conditional decision can be reached 
and be a satisfactory outcome for a consultation. 
 
Reassurance is appropriate where there are high levels of anxiety such as in a breast 
clinic, however, as demonstrated by the extract 1 in Box 3, it is also possible to be 
                                                          
1 All data from this study is available for bona fide use via the Economic and Social Data Service 
Qualidata: http://www.esds.ac.uk/qualidata/  (accessed 07.05.04) 
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clear about the temporary and tissue specific nature of the test result. Patients may 
seek certainty from health professionals because they feel vulnerable at that time or 
because they believe the myth of medical certainty. Health professionals are in a 
position of influence with patients, so in responding to a desire for certainty, they 
should critically reflect on the impact this may have on their patient now and in the 
future, such as building an expectation of certainty of outcome from medical 
interventions. The assessment of how much to emphasise certainty or not for each 
individual patient should be explicit in medical communication skills training. 
  
Negotiation between the health professional and woman was present in the 
consultations where a provisional decision was made. How much it was guided by the 
woman and how much by the health professional varied, as illustrated in Box 5. Data 
from the overall study indicates that women vary in their preference for involvement 
in decision making with health professionals this varies according to their individual 
circumstances15. It is the provisional nature of the decision, rather than the woman’s 
involvement in the decision, that seems to allow the decision to sit comfortably with 
acknowledging the uncertainty inherent in medical evidence. 
 
General practice in the UK is organised so that it is possible to make provisional 
decisions with patients and review them. It provides continuity of care for 
individuals21 of which this decision-making process is one aspect. In contrast, 
specialists may see a patient only once or review their treatment at infrequent 
intervals making it more difficult to negotiate provisional decisions. The challenge for 
all health professionals is to develop the skills to acknowledge uncertainty and 
negotiate provisional decisions including when considering test results or initiating a 
new intervention. 
 
The major types of evidence used in clinical medicine cannot be directly applied to an 
individual. The dilemma this creates is one that will remain even with further 
developments in our research methods. Through the teaching of training 
communication skills and the design of health care systems it is important to enable 
health professionals to make provisional decisions with individual patients. This 
approach to decision making has the most potential for a continuing 
acknowledgement of the inherent uncertainty in medical evidence, an uncertainty 
which will remain even with the progress in basing medical intervention on robust 
research evidence. 
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Table 1 Health care consultations recorded 
 
Health care site Health 
professionals 
recording 
consultations 
Number of relevant 
consultations recorded with each 
type of health professional 
General practice 
 
3 GPs 
2 practice nurses 
6 GP 
3 practice nurse 
General practice 
 
3 GPs 9 GP 
General practice 
 
4 GPs 
1 practice nurse 
6 GP 
2 practice nurse 
General practice 
 
3 practice nurses 
1 GP 
3 GP 
3 practice nurse 
General practice 
 
4 GPs 
1practice nurse 
 
8 practice nurse 
General practice 
 
2 GPs 
2 practice nurses 
13 practice nurse 
HRT clinic 
 
1 consultant 
1 specialist 
registrar 
 
2 consultant 
3 specialist registrar 
Breast clinic 
 
1 associate 
specialist 
1 consultant 
2 specialist nurses 
2 nurse 
4 consultant 
2 associate specialist 
Bone clinic 
 
2 consultants 
1 specialist nurse 
1 radiographer 
 
11 radiographer 
12 consultant 
1 specialist nurse 
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Table 2 Categories of approaches to uncertainty inherent in the nature of medical evidence by role of the health professional and type of 
health care setting 
13
 Health professional Focus on certainty 
‘for now’ and ‘this 
test’ with slippage 
into general 
reassurance 
Weaving a coherent 
account of the 
medical evidence for 
risks and benefits 
but with blurring of 
the uncertainty 
inherent in the 
evidence  and an 
impression of 
certainty 
 
Acknowledging the 
uncertainty of 
outcome from using 
an intervention 
including the 
inherent uncertainty 
of the medical 
evidence, and coping 
with this uncertainty 
through negotiated a 
provisional decision. 
 
Not categorised Total 
Breast assessment 
clinic doctor 
4    4 
Breast assessment 
clinic nurse 
1    1 
HRT/Bone clinic 
doctor 
 8 1  9 
Radiographer  1  1 2 
GP 2 7 8  17 
General practice 
nurse 
 3 6 3 12 
 7 19 15 4 45 
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Table 3 Categories of approaches to uncertainty inherent in the nature of medical evidence by health issue 
 Health issue 
discussed in 
consultation 
Focus on certainty 
‘for now’ and ‘this 
test’ with slippage 
into general 
reassurance 
Weaving a coherent account 
of the medical evidence for 
risks and benefits but with 
blurring of the uncertainty 
inherent in the evidence  
and an impression of 
certainty 
Acknowledging the uncertainty of 
outcome from using an 
intervention including the inherent 
uncertainty of the medical 
evidence, and coping with this 
uncertainty through negotiated a 
provisional decision. 
Total 
Concern about breast 
lump/positive 
screening result 
7 0 0 7 
Bone densitometry 
result and subsequent 
management 
0 9 1 10 
Initiation of HRT 
 
0 4 0 4 
Review of HRT usage 
or restarting after a 
break 
0 5 13 18 
Requesting 
information or referral 
for screening 
(mammography/bone 
densitometry 
0 1 1 2 
Total    41 
 
The four consultations not categorised are excluded from this table.
 
Box 1 
 
Research process detail 
 
The study 
This paper reports on data collected as part of a study funded by the ESRC Innovative 
Health Technology Programme which aims to understand the interaction between 
health technology and society. This project focused on how individual women and 
health professionals interact with the health technologies. 
 
Recruitment 
Recruitment and consent was undertaken by researchers (MT and DT) in each 
clinic/surgery waiting room over 2-4 days. The health professional started the audio-
recorder on receipt of the consent form from the woman. 
 
Analysis 
The transcripts were checked for accuracy by the researchers (MT and DT) and then 
analysed in stages. As part of the wider study, FG and EG initially read 20% of the 
consultations, identified major themes and discussed them, drawing on their different 
disciplinary backgrounds (medicine and sociology). The theme at the focus of this 
paper emerged as a key issue in the interaction of women and health professionals 
with technological health interventions. Six members of the research team (FG, EG, 
MT, DT, KMB and GB) then read three different consultations (plus interview 
transcripts from the wider study) and these were discussed. From this an initial 
categorisation was developed of how the uncertainty was dealt with in consultations. 
This categorisation was used for structuring further analysis on this issue. MT and DT 
read all the consultations, FG read 80% and PL read 20%. The content of the 
consultations with only a brief mention of the health interventions were summarised. 
Relevant part(s) of the other consultations were extracted (sometimes this was the 
whole consultation). The remaining 45 were categorised and the analytical categories 
were developed and refined through constant comparison of the extracts. All the 
consultation extracts were then reviewed by FG/PL to check their categorisation. The 
consultations were finally reviewed to categorise the health concerns discussed in the 
consultations (AL/FG). Further comparative analysis (AL/FG) explored links between 
the role of the health professional, the type of health care setting, the health concern 
discussed, and how uncertainty was dealt with. 
 
Focus groups 
The results of the analysis was presented by FG to three focus groups formed from 
existing groupings at the University of Warwick, one of GP Lecturers, one of GP 
registrars and one of patients. A limitation of this process was the lack of 
representation of clinical specialists and nurses. The groups were audio-recorded or 
detailed notes taken. All three groups recognised the dilemma of uncertainty and with 
minor refinements, affirmed the validity of the categories of consultations from their 
own experience. Their feedback was used in developing the discussion section of the 
paper. 
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Box 2 The uncertainty of medical evidence 
 
This extract is from a consultation in a Bone/HRT specialist clinic and follows a 
follow up bone density reading which showed that the woman was was ‘holding her 
own’ (bone density not decreasing). 
  
W:  I'm still on the Didronel, should I continue with it, I, I thought possibly that you 
might have said come off it now, because I understood that my level was sort of 
normal for my age now 
D: For your age, that's correct 
W: Umm, so I wondered possibly if  that's why I was coming to see you today, you'd 
maybe say I had to come off it but if you  feel that I should continue with it, I'm quite 
happy to do that. 
D: Umm, as long as there's no problems with it  
W: If necessary, I don't have any problems whatsoever 
D: Umm, okay.  My view would be take a belts and braces approach.  By that I mean 
you've changed your diet, you're doing more exercise, those two things are good for 
you.  Err, taking the Didronel we know now is allowed on a long term basis 
W: Yes 
D: Err and I am a little uncertain as to which of these three strands, the diet, the 
exercise or the medication, is making the difference, but something is. 
(Consultation054) 
 
(D-Doctor; W-Woman) 
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Box 3 Focus on certainty ‘for now’ and ‘this test’ with slippage into general 
reassurance  
 
Extract 1: GP consultation - women has told the GPs about changes in her breast 
 
P: …. I just kept putting it to the back of my mind and then it was just, I thought well 
its not, it doesn’t feel right you know it was like pulling and I thought hmmm. 
D: I'll sort you out a review at the breast clinic and then they'll be able to reassure you 
fully I'm, I'm sure “ (Consultation094) 
 
Extract 2: in a breast assessment clinic 
 
While doing breast ultrasound: 
 
D: here it is looking very clear that it is an innocent kind of, er, thing. That’s why we 
don’t need to do any biopsy. 
 
After the ultrasound: 
 
D: the thing is, it doesn’t exclude you to getting something else some other place…. 
that’s the thing. I can tell about what—what is happening today, and about these ones, 
which look innocent. (Consultation003). 
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Box 4 Weaving a coherent account of the medical evidence for risks and benefits 
but with blurring of the uncertainty inherent in the evidence  and an impression 
of certainty 
 
Extract 1: A Bone/HRT clinic consultation (Consultation001) following bone 
densitometry 
 
D: …your bone mineral density is following the course you would, we would 
Expect. 
P: Right 
D: It is going down, you would expect that at this point in the menopause 
P: So it's not abnormal then or anything? 
D: It's not abnormal.. 
(The woman’s mother has osteoporosis. The doctor explains:) 
D: ..a women with a close female relative has 30%  chance of having osteoporosis just 
’cos you know they're related… 
(He then suggests she considers taking calcium and vitamin D and taking HRT. The 
woman says ‘I’ve never really been very keen on HRT’. The doctor then examines 
her and then continues:) 
D: With the constant, bone loss starts just round the very beginning that the hormones 
start to change, what we call the peri-menopause and then you're likely to lose bone 
well totally predictably to lose bone for about 10 years after the menopause so it will 
start to gradually come down.  At the moment the results are normal, you have normal 
bone mineral density but err after about 10 years it's going to drop into the below 
normal range, you can't be certain, but it's predictable, err, and it's obviously what's 
happened to your Mum…. 
(There followed further very detailed explanation of the role of HRT, its benefits and 
risks including numerical expressions of risk with the woman saying very little until 
the doctor says:) 
D: ..effectively the choice is yours. 
P: Right 
D: Err, it doesn't suit everybody, really the only way to know if it's going to suit you 
is to try for a time 
P: Mmmh, do you really think that I need to be on it then? 
D: Err 
P: Do you think that if I don't go on it I'm going to end up more with osteoporosis 
D: I think you'll continue, you will continue to lose bone, it's quite a difficult decision 
to take because you're decision now, really you're trying to take a decision now to 
improve your health when your in your 70s and 80s with osteoporosis 
(The doctor continues with further explanation. The consultation ends with the doctor 
saying:) 
D: Anyway the choice is yours 
P: All right thank you for your time. 
 
Extract 2: GP consultation with a woman who complains of tiredness. 
 
(The GP enquires about menopausal symptoms and after some discussion the woman 
asks:) 
W: With HRT, can’t you only go on that for so long, and then they take you off? Am I 
wrong? 
 18
D: What happens with HRT is… 
W: (laughs) 
D: …right HRT…whilst you’ve got your own hormone you don’t need HRT, so your 
bones are being protected by your natural hormone. Um, and HRT you get benefit 
from for your bones, for your heart point of view, from lots of different points of 
view. Now the longer you’re on HRT from the bones point of view, the better. The 
problem is the longer you’re on it from your breast point of view, people worry about 
the increase in breast cancer. 
W: Mmm. 
D: And so what they try…it’s a balance of risks. So you take everybody individually. 
So somebody who has, a, a, wor…a concern about breasts, maybe family history of 
breast cancer or something like that, you may be a bit more cautious on that side, but 
if somebody’s got a dreadful history of thinning of the bones, and osteoporosis you 
sort of have to weigh that up, don’t you. So you’d say ‘oh well perhaps you…’ you 
know. So everybody’s individual, you weigh it up individually. The basic thing is that 
if you’re on HRT for, say, ten years, say, there is definitely an increase in risk of 
breast cancer. At five years, less so. Seven-and-a-half, it…what…up to five years is 
thought to be fairly safe. So what…that, that’s where this business about ‘you can 
only be on it a certain length of time.’ 
W: Mmm. 
D: I’ve actually got ladies that have been on it fifteen years. And are very very happy 
with it. I mean they wouldn’t stop it because it makes…it keeps them well. 
W: Mmm. 
D: So you, what you do is you balance up that good you’re getting from it, with the 
downside. 
(The consultation continues, returning to consideration of the woman’s tiredness. 
HRT is not prescribed but the woman is asked to think about it as a possibility for the 
future.) Consultation025 
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Box 5 Acknowledging the inherent uncertainty of the medical evidence and 
negotiating a provisional decision 
 
Extract 1: General practice consultation with woman concerned about taking HRT 
 
W: I've been having ‘em, HRT patches and in the middle of the year there was a new 
finding. 
D: Right, the scare 
W: Right, so when they've finished I thought, I'd try to do without them. 
D: Right 
W: And  I've been considering it and considering it - what I want to know is do you 
think - what's your opinion on it   - when we talked about – when we  talked about it 
earlier we weighed up all the pros and cons,  
D: Yes.Yes 
W: Is there a history of cancer, is there a history of heart problems - no history of 
cancer - but a history of heart problems so we decided it offered some a sort of 
protection to -  but it seems to  have taken a change - and then when I sort of thought 
about it later the percentage is quite small really isn't it .. 
D: Yes. 
W: When we, sort out how many people we're talking about it isn't large so I think 
that, I think that I'll go ahead with some more.   Is that what, is that what you would 
advise, do you think it isn't - it isn't a big risk  
D: No. - It's certainly not a big risk - how long were you been on HRT for 
W: Oh not long - less than a year 
D: OK,  that's important because there's also risks associated with time that you're on 
HRT, so basically the longer you're on, the risk goes up, particularly if you’re looking 
at breast cancer, but having said that you're absolutely right, the risk is still very small 
so any risk that there is only affects a very  tiny minority of women and of course its 
very difficult to know whether if something happens to you whether its this or  more 
likely whether it would have happened anyway. 
W: And I was thinking of the quality of my life as well - my young lad I really need a 
bit more energy 
D: Well that's important too.(laughing) 
(discussion continues, blood pressure is checked – towards the end of the consultation 
the doctor says:) 
D: so I'll just give you some more now - and then what we do .. if you’re happy with 
them you can either come and see one of us or see (practice nurse) in six months for 
the next lot…… (consultation072) 
 
Extract 2 General practice consultation to review HRT 
 
W: Err  my Estraderm patches, I'm getting a new prescription today, now the last time 
I saw the nurse, she said this would be my last prescription and I wouldn't be able to 
have any more.  
D: Did she mean because..  
W: Because of my age or something  - and I thought well I'll come and see you, 
because I did funnily enough try to come off patches myself, and I still got very 
flushed, so I thought I better just pop in and see you while I'm here anyway.  
D: Yes, I mean you’re 62 and therefore, sort of ten years beyond a natural menopause 
but you had a pretty dramatic menopause - you've had your ovaries taken out 
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W: Oh I've had all sorts 
D: I guess, she may have been thinking in terms of osteoporosis prevention, in that ten 
years would be adequate for that and also as you also will know, a longer term use of 
HRT is associated with breast cancer, however, if you feel that you'd rather carry on, 
bearing in mind you know the increased risk of breast cancer.  
W: Yes 
D: You know the big one, then I don't have any particular problem with this. 
W: What about after this six months I mean obviously it’s - would it  -if I only say 
tried one a week instead of two how would that -or don't you do that with HRT. 
D: Well, or else what you could well, - I'm just looking to see if they come in 25’s - if 
you put one a week on, you'd be fine for the first half of the week and then ... 
W: Sure enough. 
D: Yes, they come in 25's so one option might be to draw three months of the 25's to 
see how you get on. 
W: Yes, yes 
D: You might find that when you decide to stop you have no hot flushes or you know 
whatever you got when you last decided to stop.   But I think she probably just felt 
that that she would flag it up about breast cancer, (Consultation002). 
 
Extract 3: consultation with Nurse in general practice 
The woman and nurse have discussed the increase in breast cancer risk with taking 
HRT longterm shown by the US study as reported in the media. The woman is feeling 
very well on HRT. 
 
N: ...but there is still a risk of breast cancer - but there again there is a risk of breast 
cancer in this age group anyway, but it is increased with long term use of  
W: Well when you say long term use of ... 
N: Long term - 10 years plus  
W: Oh, I'm getting up to that one now aren't I  - 8 years isn't it. 
N: Yes, that's right  - they advise five years, fine, up to ten years is okay and then to 
re-think about it. 
W: Well I mean by then I might be okay we'll just have to wait and see. 
N: That's right - blood pressure's fine - but it is something that you've got to be aware 
of. 
W: Oh yes, I realize that - yes. (N) Consultation083 
(N – Nurse) 
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What this paper adds 
Intrinsic to the nature of medical evidence is uncertainty about outcome for an 
individual patient. This creates a dilemma that will always be present. 
Communicating evidence to patients is a key part of clinical consultations with a 
growing evidence base of how it is best achieved. 
 
This study focuses on how the uncertainty inherent in medical evidence is dealt with 
in consultations. It identifies the danger of creating a myth of certainty around what is 
inherently uncertain and suggests that negotiating provisional decisions may avoid 
this danger. The dilemma created when applying medical evidence to an individual 
needs to be remembered when developing and teaching skills for communicating 
about medical evidence in consultations. 
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Information sheet used to obtain informed consent: 
 
INFORMATION FOR RESEARCH PARTICIPANTS 
 
Research Project Title: Innovative Health Technology at Women’s Midlife 
 
You are being invited to take part in a research study. Before you decide to participate 
it is important that you understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. If anything is 
not clear or you would like more information please contact a member of the research 
team by asking the person handing you this information sheet. Take time to decide 
whether or not you wish to take part.  Thank you for reading this.  
 
Purpose of the Research 
 
As women reach midlife they are offered the use of health technology such as 
screening for breast cancer using ‘breast awareness’ advice and mammography (X-ray 
of breast), checking for a high risk of osteoporosis (brittle bones) using bone 
densitometry, and the use of hormone replacement therapy (HRT) for the prevention 
of osteoporosis and cardiovascular disease.  
 
This research project aims to find out from women (aged 45-64) and from health care 
professionals (doctors and nurses) what they think about these health technologies, 
how they approach the decision to use them or not, and what they do when facing 
these decisions. The research aims to include women and health care professionals 
with a wide variety of life experiences. The research will be used to inform how 
health technologies are developed and offered in the future. With many new 
technologies being developed it is important that the views of the people using health 
technology are included in the debates on their development and use.  
 
Why have you been chosen? 
 
You have been chosen to be invited to take part in this research as you are between 
the age of 45 and 64 and are attending the general practice surgery/clinic during the 
week that the research team are present in the practice/clinic. The practice/clinic has 
agreed to be part of the study and will be contributing their views to the study.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. You 
will be given a copy of the signed consent form to keep. If you decide to take part you 
are still free to withdraw at any time and without giving a reason. This will not affect 
the standard of care you receive.  
 
What does the study involve? 
 
The research project involves interviews with women and health care professionals. 
Some of these individuals will also be asked to record their consultations about HRT, 
breast screening or osteoporosis, with their doctor/nurse/patient. All the interviews 
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and consultations will be tape recorded. The recordings will then be typed up by a 
research secretary. The typed version will omit names and any other identifying 
factors so the transcript will be anonymous. Only the research team will know who 
gave which interview or consultation and this information will remain confidential to 
the research team.  
 
The interviews and consultations will be analysed and a research report written by the 
research team. The research may be published in professional and academic 
journals/books to inform others of the research findings and may be discussed and 
written about more generally. Any quotes taken from the interviews/consultations will 
be anonymous.  
 
To ensure future researchers do not do unnecessary data collection on similar issues 
the ESRC maintains an archive of research data. The anonymised transcripts from this 
research project will be placed in an archive by the ESRC Qualitative Data Archival 
Resource Centre (Qualidata). Access to the data in the future would be monitored by 
Qualidata and restricted to bona fide researchers only.  
 
What we are asking from you 
 
The research team is asking you to allow your consultation with the doctor or nurse to 
be tape recorded. The main reason for you attending the clinic/surgery need not be 
connected to the topic of the research for the recording of the consultation to be of use 
for the research project. 
 
We are also asking you to agree to being approached for an interview at a later date. If 
you are not asked for an interview the tape recording of your consultation will still be 
valuable data. If you are asked for an interview the researcher will endeavour to find a 
time and place convenient for you. The interview will last approximately one hour. 
The interview will be tape-recorded. 
 
Who is organising and funding the research? 
 
This research project is funded by the Economic and Social Research Council of the 
UK (ESRC) and is being conducted by researchers from the Universities of Teesside, 
Warwick and Edinburgh.  
 
The Research team:  
 
Project Leader: 
Dr. Frances Griffiths, Centre for Primary Health Care Studies, University of Warwick 
 
Project Supervisors: 
Professor Eileen Green, Director of the Centre for Social Policy Studies, University of 
Teesside 
Dr Kathryn Backett-Milburn, Senior Research Fellow, Research Unit in Health & 
Behavioural Change, University of Edinburgh 
Dr Gillian Bendelow, Lecturer, Sociology Department, University of Warwick 
 
Researchers: Dr Maria Tsouroufli and Dr Di Thompson 
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The ESRC is funding the salaries of the researchers. Your doctor or nurse is not 
receiving any payment for participating in the study.  
 
Who has reviewed the study? 
 
This study has been approved by the Economic and Social Research Council and by 
the NHS Research Ethics Committee in your locality. (North Tees/South 
Tees/Warwickshire). 
 
Contact for further information 
 
If you have any questions about this research project please contact the research 
project office nearest you.  
 
Centre for Primary Health Care Studies 
University of Warwick 
Coventry 
CV4 7AL 
 
Tel: 024 765 72950 
Fax: 024 765 28375 
e-mail: f.e.griffiths@warwick.ac.uk 
 
Centre for Social & Policy Research 
University of Teesside 
Middlesborough 
TS1 3BA 
 
Tel: 01642 342346 
Fax: 01642 342396 
e-mail: e.e.green@tees.ac.uk 
 
 
 
PLEASE RETAIN THIS INFORMATION SHEET FOR YOUR FUTURE 
REFERENCE. THANK YOU FOR TAKING TIME TO READ THIS.  
 
 
 
 
